Castle Biosciences Inc (CSTL)
23.77
-0.64
(-2.62%)
USD |
NASDAQ |
May 07, 16:00
23.76
-0.01
(-0.04%)
After-Hours: 20:00
Castle Biosciences Research and Development Expense (TTM): 53.03M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 53.03M |
| December 31, 2023 | 53.62M |
| September 30, 2023 | 51.93M |
| June 30, 2023 | 49.92M |
| March 31, 2023 | 48.54M |
| December 31, 2022 | 44.90M |
| September 30, 2022 | 43.04M |
| June 30, 2022 | 39.63M |
| March 31, 2022 | 34.50M |
| December 31, 2021 | 29.65M |
| September 30, 2021 | 24.78M |
| Date | Value |
|---|---|
| June 30, 2021 | 20.34M |
| March 31, 2021 | 16.25M |
| December 31, 2020 | 13.26M |
| September 30, 2020 | 11.83M |
| June 30, 2020 | 10.29M |
| March 31, 2020 | 8.904M |
| December 31, 2019 | 7.385M |
| September 30, 2019 | 5.364M |
| June 30, 2019 | 5.143M |
| March 31, 2019 | 4.985M |
| December 31, 2018 | 4.854M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
5.143M
Minimum
Jun 2019
53.62M
Maximum
Dec 2023
28.62M
Average
27.21M
Median
Research and Development Expense (TTM) Benchmarks
| Exact Sciences Corp | 425.88M |
| Illumina Inc | 1.353B |
| Mettler-Toledo International Inc | 185.28M |
| Waters Corp | 174.94M |
| Natera Inc | 320.68M |